3 clinics shown
Dr. Guohua Xia operates a psychiatric practice in Davis, located on Madson Place near the UC Davis campus area. The practice provides psychiatric evaluations and medication management for adults. Specific treatment modalities such as TMS, esketamine, or ketamine therapy are not detailed in available information; prospective patients should inquire directly about specialized treatment options beyond standard psychiatric care.
Mindpath College Health operates a psychiatry and therapy practice on E Street in Davis, serving college-age and young adult patients with mental health concerns. The clinic provides psychiatric evaluations, medication management, and psychotherapy through licensed psychiatrists and therapists. Services focus on conditions common in university populations, including depression, anxiety, ADHD, and adjustment disorders. Specific procedural treatments like TMS or esketamine are not listed in available data.
Mental health clinic in Davis, California.
Spravato is the brand name for esketamine, an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation. It's derived from ketamine and works on the brain's glutamate system — a different mechanism than traditional antidepressants like SSRIs.
Treatment is administered only at REMS-certified clinics under direct medical supervision. Patients self-administer the spray under a clinician's guidance, then remain at the clinic for at least two hours of monitoring after each dose. The induction phase typically involves twice-weekly sessions for four weeks, followed by weekly or biweekly maintenance dosing depending on response.
Many patients report meaningful symptom improvement within the first one to two weeks — substantially faster than the 4 to 8 weeks typical of oral antidepressants. Spravato is taken alongside an oral antidepressant, not as a replacement.
The most common side effects are dissociation, dizziness, sedation, and elevated blood pressure during and shortly after dosing. These typically resolve within the two-hour monitoring window. Patients cannot drive on the day of treatment.
Most commercial insurance and Medicare cover Spravato for treatment-resistant depression with prior authorization. Clinics offering Spravato in our directory hold active REMS certification and are staffed to provide the required in-clinic monitoring period.